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Abstract: Research on calcium phosphate use in the development and clinical application of
biomedical materials is a diverse activity and is genuinely interdisciplinary, with much work leading
to innovative solutions for improvement of health outcomes. This Special Issue aimed to summarize
current advances in this area. The nine papers published cover a wide spectrum of topical areas,
such as (1) remineralisation pastes for decalcified teeth, (2) use of statins to enhance bone formation,
(3) how dolomitic marble and seashells can be processed into bioceramic materials, (4) relationships
between the roughness of calcium phosphate surfaces and surface charge with the effect on
human MRC osteogenic differentiation and maturation being investigated, (5) rheological and
mechanical properties of a novel injectable bone substitute, (6) improving strength of bone cements
by incorporating reinforcing chemically modified fibres, (7) using adipose stem cells to stimulate
osteogenesis, osteoinduction, and angiogenesis on calcium phosphates, (8) using glow discharge
treatments to remove surface contaminants from biomedical materials to enhance cell attachment and
improve bone generation, and (9) a review on how classically brittle hydroxyapatite based scaffolds
can be improved by making fibre-hydroxyapatite composites, with detailed analysis of ceramic crack
propagation mechanisms and its prevention via fibre incorporation in the hydroxyapatite.
Keywords: calcium phosphates; hydroxyapatite; scaffolds; biomedical; biocompatibility; bone substitute;
bone regeneration
1. Introduction
The diversity of research on the development and use of calcium phosphate based biomedical
materials gives rise to a thoroughly interesting and extremely interdisciplinary field of activity,
from which many innovative advances can be realized for improving human health.
The importance of the field in today’s times is of unquestionable importance. Bohner [1] has
commented that bone related medical conditions and bone breaks have increased due to the progressive
ageing of the global population and the popularity of high risk sporting activities. In terms of the
ageing aspect, Habraken et al. [2] have cited expert opinion that in the near future, 30% of all hospital
admissions will be taken up by osteoporosis patients.
In general, the main reason for pursuing calcium phosphate based bone substitutes is to reduce
dependence on autologous bone, which is harvestable only in limited quantities from the iliac crest,
and which necessarily subjects the patient to two surgical procedures. Donor site morbidity is also
an issue. Allografts, on the other hand, are more plentiful in supply but have been said to lead to
inferior healing outcomes relative to autologous bone and can potentially be a vector for disease
transmission [3]. As calcium phosphate-based bone substitutes are similar in chemical composition
to human bone, these have been subjected to the most research scrutiny and are relatively easy to
manufacture or to source from natural sources. It is for this reason that advances in calcium phosphate
based biomedical materials form the dominant subject of this Special Issue.
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Numerous reviews on state-of-the-art calcium phosphate biomaterials (and indeed biomaterials
in general, constructed from other non-calcium phosphate materials) have been written. Some of these
have been general in nature but others have concentrated on specific aspects or materials being actively
worked upon in the field. Examples include “biphasic calcium phosphates (BCPs)” which have been
described as the “gold standard of bone substitutes in bone reconstructive surgery” [4]. BCPs consist
of varying mixtures of hydroxyapatite (HAp) and beta tricalcium phosphate (β-TCP), with the degree
of solubility of the ceramic mixture being important. The behaviour of osteoclastic resorption was
found to be influenced by the HAp/ β-TCP ratio [4]. BCPs (the term being in existence since 1986)
have been successfully employed for bone reconstructive purposes in a variety of clinical situations.
Other biomedical materials reviews have summarized the importance of naturally derived materials,
such as animal bone (cattle bone, fish bone, etc.), in providing a feedstock source for creating calcium
phosphate based materials [5]. Another active area of study is bone cements [6], which are widely
used in bone reconstructive surgery due to their excellent bioresorbability, which obviates the need for
xenografts or allografts that may be only semi absorbed. These materials are also useful as delivery
vehicles for medications, such as antibiotics used to combat infection and biofilm production that often
find an ideal milieu to proliferate on implants or bone replacement materials implanted in vivo.
Research surrounding the effects of cationic or anionic substitutions into hydroxyapatite on its
biofunctionality is also a vast activity, currently with much written the subject, as is evident in this
recent review by Tite et al. [7], though this only concentrates on cationic substitutions. The doping of
cations or anions into hydroxyapatite has been shown to have a number of beneficial effects, such as
increasing biological activity in terms of cytocompatibility, cell viability and proliferation, adhesion,
haemocompatibility, antimicrobial or antifungal factors, among other effects. However, the field is
crowded with many different studies, and some degree of comparison between studies to ascertain the
best procedures to follow is needed to drill down into what exactly is causing the beneficial effects of
a cation or an anion substituted HAp lattice.
Ceramic composites are also an active area of study [8], with the intent being to more closely mimic
bone, which can be described as a living composite of bone and collagen [9]. Synthetic HAp on its own
is too brittle and clearly unsuitable for load-bearing applications due to the risk of cracking and failure.
Composite scaffold production has the aim of producing materials with superior mechanical properties.
Other work has shown that processing conditions and controlling aspects as fundamental as the
pH of the solution in which the hydroxyapatite is generated can influence biological response [10].
This can alter surface properties, such as zeta potential, which can, among other factors, dictate the
success of cell interactions with the implanted biomedical material.
2. Synopsis of Papers Contributed to the Special Issue
In discussing some of the main areas of biomedical materials research involving calcium
phosphate-based materials above, this Special Issue aimed to attract papers describing the latest
advances, and successfully led to nine papers being accepted for publication that provide a very
interesting snapshot into some very topical areas of biomedical research involving calcium
phosphate-based materials. A brief summary of these is provided below and interested readers
are invited to seek further information by referring to the actual articles embodied in this Special Issue.
The paper by Bakry et al. [11] contains a dental materials research theme. Orthodontic patients
can frequently suffer from decalcification of enamel surfaces adjacent to their orthodontic devices
due to problems with oral hygiene. These so-called white spot lesions are difficult to treat and
can lead to dental caries, which can become unsightly. This paper examined the use of a novel
fluoride-containing bioactive glass paste known as BiominF for remineralization of white spot
lesions associated with orthodontic treatment. The study used transverse micro radiography and
scanning electron microscopy/energy dispersive spectroscopy (SEM/EDS) techniques to observe
remineralization events on enamel demineralized surfaces.
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In the paper by Rakhmatia et al. [12], an investigation into how statins can enhance bone
formation was carried out. This was executed by evaluating how readily apatite blocks made via
a dissolution-reprecipitation reaction, involving preset gypsum in the presence and absence of statins,
could increase bone formation in a socket healing scenario after tooth extraction. Four week old male
Wistar rats were used as the model to test this hypothesis. Carbonate apatite containing statins were
found to exhibit very favourable results for enhancing bone mineral density in the vertical plane
showing it could not only allow but promote bone healing in socket healing. This result could, in the
future, be a strategy for the preservation of alveolar bone after tooth extraction.
The research reported in this paper by Mitran et al. [13] followed the theme of deriving biomedical
materials from naturally sourced feedstocks. Bioceramic materials were obtained from processing of
dolomitic marble and indigenously sourced Mytilus galloprovincialis seashells via the decomposition of
the calcium carbonate minerals contained within the natural powders into CaO, hydrolysis to form
Ca(OH)2, and then mixing with phosphoric acid to form pellets. These were found to contain a biphasic
composition involving largely hydroxyapatite and brushite. These were then evaluated for their bone
regenerative capabilities by investigating the interaction of pre-osteoblastic cells, namely MC3T3-E1
cells, with the materials in terms of their adhesion properties, morphological characteristics, viability,
proliferation, and differentiation. The Mytilus galloprovincialis seashell-derived material was found,
in particular, to efficaciously induce cell differentiation in these studies on a par with the performance
of the reference hydroxyapatite materials used.
Khlusov et al.’s paper [14] detailed the very interesting area of surface electrical charge and
topography of biomedical materials and their influence on cell responses to these materials.
In this in vitro study, the authors investigated the relationship between the roughness of calcium
phosphate surfaces and the surface electrical charge, and its possible role in affecting human MSC
(mesenchymal stem cells) osteogenic differentiation and maturation. The behaviour of these in vitro
was estimated by human adipose-derived MSCs or prenatal stromal cells from the human lung.
A microarc calcium phosphate coating was prepared on a titanium substrate and characterized,
although was found to be amorphous to X-ray in its as-prepared form, hence necessitating its annealing
at 1073 K to crystallize the phases present to enable identification. These were revealed to be a mixture
of calcium titanium phosphates, calcium/titanium pyrophosphates, and anatase. The authors then
used human adult adipose derived MSCs or human lung derived prenatal stromal cells (abbreviated
in the paper as “HLPSCs”) and cultured them on the calcium phosphate surfaces to estimate MSC
behaviour. It was demonstrated that roughness, non-uniform charge polarity, and the electrical
potential of the microarc coatings affected the osteogenic differentiation and maturation of the cells
in vitro. Electrical potential on the surface of the coatings increased with increasing roughness at the
surface (at microscale). It was found that nanoscale surface features influenced the sign of the electrical
potential with location of negative electrical charges mostly existing in micro and nanosockets of the
coating surface. Positive charges mostly existed at nanorelief peaks. In the sockets, HLPSCs were
located and expressed osteoblastic markers osteocalcin and alkaline phosphatase. The topography of
the coating promoted the osteoblast phenotype of HLPSCs. Overall, it was thought that the negative
sign existing at the calcium phosphate surfaces and its magnitude at various locations corresponding
to micro and nanosockets could be factors that stimulate osteoblastic differentiation and maturation of
human stromal cells.
Rheological and mechanical properties of a novel injectable bone substitute are the theme of the
paper by Oğuz et al. [15]. This was accomplished by mixing a bioceramic powder in a solution of
polymers consisting of methylcellulose, gelatin, and citric acid. Methylcellulose was used because
of its thermoresponsive and biocompatibility properties. Added gelatin and citric acid served to
adjust rheological properties in the injectable bone substitute. The bioceramic powder component
comprised tetracalcium phosphate, hydroxyapatite, brushite, and calcium sulfate dihydrate, which was
added in proportions up to 50 wt%. The so-prepared injectable bone substitute had a “chewing
gum” consistency. Characterisation was carried out on the materials in terms of chemical structure,
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rheological, and mechanical properties. Hardening of the injectable material was confirmed at
physiological temperature. In addition, in vitro degradation studies were carried out. These indicated
a lower rate of degradation as the wt% of bioceramic powder increased, with a concomitant
improvement in mechanical properties. Overall, the injectable bone substitute material was judged
a promising candidate for treatment of bone defects in non-load bearing applications.
In yet another bone-cement-themed paper, this time by Boehm et al. [16], the authors considered
solutions to the long term and well known problem of the brittleness of calcium phosphate cements,
which leads to low fracture toughness. This, of course, limits them to non-load bearing applications in
clinical practice. Carbon fibre reinforcement is known to improve fracture resistance, but at the same
time compromise strength of the composite. It was found that chemically modifying the fibre surfaces
and using these fibres to reinforce the calcium phosphate cements resulted in a modification of the
fibre matrix interface and the fracture behaviour. In taking this approach, the authors were able to
demonstrate enhanced mechanical properties as regards bending strength and work of fracture to
a strain of 5%. They found that using fibre reinforcement did not affect the cell proliferation and activity
of MG63 (human osteoblast-like) cells that were used as biocompatibility markers. The conclusion was
that the use of chemically activated C-fibres to reinforce calcium phosphate cements was a promising
method to achieve better mechanical properties in these bone cement replacement materials to the
extent that they might be of use in load bearing applications.
Farré-Guasch et al.’s paper [17] tries to address the classical issue encountered with xenograft type
materials in regard to their lack of osteoinductive and angiogenic properties. This paper concentrated
on the potential of adding adipose stem cells (ASC) to calcium phosphate based scaffolds in order
to stimulate osteogenesis, osteoinduction, and angiogenesis in them. The bone substitute (“calcium
phosphate carrier”) materials used for seeding the (autologous) ASC-containing stromal vascular
fraction from ten patients were (pure) β-tricalcium phosphate and biphasic calcium phosphate.
These were used in a human maxillary sinus floor elevation model in a one-step surgical procedure.
After six months of implantation, biopsies collected quantified blood vessel formation and bone
percentages. Bone percentages were found to correlate with blood vessel formation and were higher
in study subjects compared to control biopsies in the cranial area. This was particularly so with the
β-tricalcium phosphate blocks. The study showed the pro-angiogenic effect of using the stromal
vascular fraction to seed the calcium phosphate scaffolds.
The paper by Salamanca et al. [18] is concerned with surface treatments for the purpose
of removing contaminants on biomedical material surfaces. To achieve this, glow discharge
plasma treatments on calcium phosphate biomaterial surfaces were carried out. The point of
removing contaminants was in order to facilitate cell attachment and enhance bone regeneration.
These contaminants can arise from inorganic grit blasting media (which can be Si or Al-based oxides)
residues or layers arising from processing fluids, such as etchants or cleaning solvents, or substances
that remain after sterilization procedures, like autoclaving or the use of ethylene oxide. In addition,
most surfaces exposed to ambient air can pick up organic contamination (often known as “adventitious
hydrocarbons” in surface science [19]). In this study, calcium phosphate composite materials consisting
of hydroxyapatite and β-tricalcium phosphate were treated with argon glow discharge plasma
for 15 min at room temperature and were then subjected to scanning electron microscopy/energy
dispersive spectroscopic (SEM/EDS) analysis. These showed that low levels of metal ion impurities
at the surface had been removed by the glow discharge process. Other biological tests, such as cell
viability, morphology, and an alkaline phosphatase assay, were also conducted on untreated and glow
discharge treated calcium phosphate surfaces and compared to controls. Improved cell proliferation,
increased alkaline phosphatase activity, and enhanced differentiation into osteoblast like cells were
observed after 5 days on the argon glow discharge treated substrates. No chemical modification was
noted to occur to the bulk calcium phosphate materials. Thus, the improvement was directly ascribed
to the argon glow discharge treatment of the surface, though it was recommended that further testing
be conducted in the in vivo models to further prove its efficacy.
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The review by Siddiqui et al. [20] discusses the use of hydroxyapatite as a bone-substituting
and osteoconductive scaffold, but also comments on the classical problem of implants made from
(pure) hydroxyapatite having poor mechanical properties when placed under load. This limits their
usage to non-load bearing applications. In order to make hydroxyapatite more suitable for load
bearing applications or to achieve better mechanical properties, it is necessary to create composites of
hydroxyapatite with other materials, whilst maintaining the biocompatibility of the resultant material.
The review then moves on to discuss the strengthening and toughening mechanisms which are
crucial to understand if the aim is to produce new and optimized materials from the compositing
approach. The main engineering conundrum when designing a material that is both strong and tough
is that often an increase in strength can be coupled with a decrease in toughness, and vice versa.
A detailed discussion is provided on fracture mechanics, which constitutes a valuable tool to analyze
the conditions under which a crack may propagate and eventually lead to failure. Further discussion
concentrates on how crack propagation can be prevented, which in brittle ceramic materials is known
as a process of extrinsic toughening.
3. Concluding Remarks
As is obvious, a diverse range of topics has been covered in this Special Issue, although it is clear
that there is an underlying emphasis on how the biological processes, such as cell proliferation and
others, can be facilitated or enhanced on the prepared calcium phosphate biomaterials when implanted.
This remains of critical importance when engaging in this research area. It is hoped that the readers
will find this collection of research of interesting reading for advancing understanding in calcium
phosphate-based biomaterials.
Conflicts of Interest: The author declare no conflict of interest.
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